METOCLOPRAMIDE HYDROCHLORIDE

METOCLOPRAMIDE HYDROCHLORIDE was reported 77711 times

METOCLOPRAMIDE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FAMILY STRESS 1934 0.6231
1 LYMPHOID TISSUE HYPOPLASIA 88 0.5752
2 TARDIVE DYSKINESIA 16219 0.5743
3 EXTRAPYRAMIDAL DISORDER 12922 0.5199
4 THYMUS HYPOPLASIA 89 0.5115
5 DYSTONIA 7119 0.3667
6 MULTIPLE INJURIES 2243 0.3559
7 GRIMACING 234 0.2996
8 VAGINAL FLATULENCE 82 0.2706
9 ECONOMIC PROBLEM 3962 0.2612
10 DEFORMITY 2421 0.2588
11 NERVOUS SYSTEM DISORDER 7527 0.2409
12 NEOVASCULARISATION 58 0.2205
13 EXCESSIVE EYE BLINKING 290 0.1961
14 DISSEMINATED ASPERGILLOSIS 83 0.1758
15 PARKINSON'S DISEASE 396 0.1557
16 QUALITY OF LIFE DECREASED 2085 0.1552
17 ACTIVITIES OF DAILY LIVING IMPAIRED 2932 0.1479
18 DIABETIC GASTROPARESIS 53 0.1444
19 CHOREA 244 0.1415
20 AKATHISIA 1903 0.1393
21 INCORRECT DRUG ADMINISTRATION DURATION 3710 0.1318
22 ESSENTIAL TREMOR 140 0.1254
23 DEPRESSION SUICIDAL 370 0.1068
24 COMPUTERISED TOMOGRAM THORAX ABNORMAL 73 0.1063
25 MOVEMENT DISORDER 3273 0.1018
26 PROTRUSION TONGUE 56 0.0961
27 STEREOTYPY 80 0.0848
28 MULTIPLE DRUG THERAPY 60 0.0796
29 PARTNER STRESS 76 0.0793
30 DYSKINESIA 3227 0.0793
31 ANHEDONIA 1798 0.0684
32 FEAR 1796 0.0667
33 PARKINSONISM 616 0.0631
34 NEPHROGENIC ANAEMIA 290 0.0625
35 METABOLIC DISORDER 359 0.0618
36 HYPERPARATHYROIDISM SECONDARY 151 0.0602
37 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 63 0.0593
38 FEMALE GENITAL TRACT FISTULA 101 0.0591
39 NEUTROPENIC SEPSIS 376 0.0526
40 APLASTIC ANAEMIA 273 0.0522
41 SYSTEMIC INFECTION 79 0.0476
42 RESTLESS LEGS SYNDROME 863 0.0474
43 RADICULOPATHY 117 0.0444
44 OCULOGYRIC CRISIS 91 0.0424
45 CHRONIC SINUSITIS 148 0.0394
46 SUBILEUS 80 0.0384
47 IMPAIRED GASTRIC EMPTYING 519 0.0380
48 EMOTIONAL DISORDER 1146 0.0371
49 PROCTITIS 101 0.0360
50 REBOUND ACID HYPERSECRETION 108 0.0357
51 BILIARY DYSKINESIA 60 0.0353
52 FEBRILE NEUTROPENIA 2338 0.0352
53 COLONIC POLYP 58 0.0351
54 ATELECTASIS 336 0.0347
55 LONG QT SYNDROME 82 0.0342
56 TORTICOLLIS 65 0.0306
57 GASTRIC POLYPS 69 0.0305
58 ESCHERICHIA BACTERAEMIA 71 0.0302
59 SEROTONIN SYNDROME 564 0.0293
60 BLOOD BICARBONATE DECREASED 52 0.0274
61 CHOLECYSTITIS CHRONIC 182 0.0272
62 NEUTROPENIC COLITIS 55 0.0266
63 END STAGE RENAL DISEASE 484 0.0265
64 GASTROINTESTINAL HYPOMOTILITY 59 0.0262
65 MENTAL DISORDER 1121 0.0257
66 PEPTIC ULCER 85 0.0256
67 CLONUS 70 0.0256
68 TORSADE DE POINTES 198 0.0252
69 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 67 0.0252
70 FAILURE TO THRIVE 123 0.0237
71 BLOOD CHLORIDE DECREASED 61 0.0236
72 IMPAIRED WORK ABILITY 505 0.0236
73 HYPOMAGNESAEMIA 326 0.0234
74 AORTIC ARTERIOSCLEROSIS 60 0.0233
75 CLOSTRIDIUM DIFFICILE COLITIS 245 0.0231
76 DIABETIC NEUROPATHY 113 0.0228
77 TOXIC EPIDERMAL NECROLYSIS 343 0.0226
78 THERAPEUTIC AGENT TOXICITY 75 0.0225
79 NON-CARDIAC CHEST PAIN 71 0.0224
80 BACTERIAL TEST POSITIVE 50 0.0224
81 DIABETES INSIPIDUS 53 0.0220
82 MUCOSAL INFLAMMATION 576 0.0220
83 ILEUS 273 0.0219
84 HYPOKALAEMIA 1011 0.0219
85 HYPERREFLEXIA 76 0.0218
86 DISTURBANCE IN SOCIAL BEHAVIOUR 51 0.0216
87 ORAL INTAKE REDUCED 52 0.0215
88 BLOOD MAGNESIUM DECREASED 183 0.0212
89 LEFT VENTRICULAR DYSFUNCTION 142 0.0212
90 LOSS OF EMPLOYMENT 64 0.0212
91 MALNUTRITION 237 0.0212
92 CYTOKINE RELEASE SYNDROME 419 0.0209
93 NEUTROPHIL COUNT ABNORMAL 59 0.0209
94 ABDOMINAL TENDERNESS 103 0.0207
95 BRUXISM 111 0.0206
96 RENAL FAILURE CHRONIC 158 0.0205
97 HIATUS HERNIA 266 0.0205
98 OESOPHAGITIS 224 0.0205
99 CANCER PAIN 52 0.0203
100 NEPHROGENIC SYSTEMIC FIBROSIS 61 0.0202
101 VITAMIN B12 DECREASED 58 0.0201
102 ANXIETY DISORDER 67 0.0200
103 CYTOMEGALOVIRUS VIRAEMIA 89 0.0200
104 CACHEXIA 102 0.0198
105 PROTEIN TOTAL DECREASED 74 0.0196
106 BLOOD ALBUMIN DECREASED 152 0.0191
107 ATRIOVENTRICULAR BLOCK FIRST DEGREE 82 0.0189
108 DUODENITIS 58 0.0189
109 SPINAL OSTEOARTHRITIS 166 0.0189
110 HYPOALBUMINAEMIA 146 0.0188
111 BLOOD CREATININE DECREASED 58 0.0185
112 ELECTROLYTE IMBALANCE 215 0.0185
113 HYPOPHOSPHATAEMIA 136 0.0184
114 PATENT DUCTUS ARTERIOSUS 73 0.0184
115 INJURY 1265 0.0180
116 EMOTIONAL DISTRESS 2157 0.0178
117 DYSAESTHESIA 54 0.0176
118 UNEVALUABLE EVENT 1330 0.0176
119 ENTERITIS 112 0.0175
120 BRADYKINESIA 103 0.0174
121 LUNG INFILTRATION 154 0.0174
122 ORTHOPNOEA 55 0.0173
123 PANCREATIC CARCINOMA METASTATIC 49 0.0172
124 STAPHYLOCOCCAL SEPSIS 85 0.0172
125 MYOCLONUS 204 0.0171
126 JAUNDICE CHOLESTATIC 60 0.0170
127 BACTERAEMIA 201 0.0169
128 PARADOXICAL DRUG REACTION 62 0.0168
129 GASTRITIS 443 0.0168
130 TRICUSPID VALVE INCOMPETENCE 133 0.0167
131 METASTASES TO SPINE 56 0.0166
132 MASTICATION DISORDER 51 0.0166
133 MIXED LIVER INJURY 50 0.0166
134 HYPERLIPIDAEMIA 198 0.0166
135 STAPHYLOCOCCAL BACTERAEMIA 72 0.0165
136 HYDRONEPHROSIS 124 0.0165
137 ORAL CANDIDIASIS 218 0.0165
138 SMALL INTESTINAL OBSTRUCTION 203 0.0165
139 NEUROLEPTIC MALIGNANT SYNDROME 195 0.0164
140 CHRONIC KIDNEY DISEASE 1246 0.0164
141 RHINOVIRUS INFECTION 63 0.0162
142 TREMOR 2676 0.0161
143 CEREBRAL ATROPHY 64 0.0160
144 ILEUS PARALYTIC 71 0.0159
145 CHOLECYSTITIS 188 0.0158
146 TRANSFUSION 165 0.0157
147 LEFT VENTRICULAR HYPERTROPHY 67 0.0156
148 SINUS TACHYCARDIA 222 0.0156
149 ENTEROCOLITIS 90 0.0156
150 BLOOD CREATINE INCREASED 69 0.0156
151 ODYNOPHAGIA 93 0.0156
152 CHOLECYSTITIS ACUTE 87 0.0153
153 ELECTROCARDIOGRAM QT PROLONGED 551 0.0153
154 RENAL TUBULAR NECROSIS 150 0.0153
155 CARDIOMEGALY 188 0.0153
156 AZOTAEMIA 61 0.0153
157 CANDIDIASIS 61 0.0152
158 HYPONATRAEMIA 854 0.0151
159 FAECALOMA 83 0.0151
160 WOUND DEHISCENCE 51 0.0151
161 SNORING 57 0.0151
162 HYPOXIA 531 0.0151
163 MUSCLE RIGIDITY 180 0.0150
164 HYPOVOLAEMIA 88 0.0150
165 ARTERIOSCLEROSIS CORONARY ARTERY 98 0.0148
166 INTERVERTEBRAL DISC DEGENERATION 136 0.0147
167 GASTROENTERITIS 213 0.0146
168 SWOLLEN TONGUE 454 0.0145
169 BLOOD CALCIUM DECREASED 163 0.0145
170 ANXIETY 4122 0.0145
171 MITRAL VALVE INCOMPETENCE 163 0.0144
172 BLOOD UREA INCREASED 241 0.0144
173 HICCUPS 118 0.0144
174 DECUBITUS ULCER 117 0.0143
175 DIVERTICULUM 102 0.0143
176 TRISMUS 74 0.0143
177 POLYDIPSIA 56 0.0142
178 PREMATURE LABOUR 80 0.0141
179 PROTHROMBIN TIME PROLONGED 84 0.0140
180 NEUROPATHY PERIPHERAL 1325 0.0139
181 AMYLASE INCREASED 51 0.0138
182 DIVERTICULUM INTESTINAL 60 0.0137
183 NEUROLOGICAL SYMPTOM 78 0.0136
184 OESOPHAGEAL CANDIDIASIS 54 0.0135
185 PERFORMANCE STATUS DECREASED 63 0.0135
186 RENAL CYST 107 0.0135
187 RENAL FAILURE ACUTE 569 0.0134
188 PARAESTHESIA ORAL 193 0.0134
189 EJECTION FRACTION DECREASED 206 0.0132
190 BREATH SOUNDS ABNORMAL 65 0.0132
191 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 50 0.0131
192 ACUTE KIDNEY INJURY 2002 0.0131
193 INTESTINAL ISCHAEMIA 72 0.0131
194 TUBULOINTERSTITIAL NEPHRITIS 245 0.0131
195 PATHOLOGICAL FRACTURE 66 0.0130
196 OESOPHAGEAL ULCER 50 0.0130
197 TONGUE DISORDER 94 0.0130
198 BUNDLE BRANCH BLOCK LEFT 55 0.0130
199 PLEURAL EFFUSION 785 0.0129
200 ATRIAL SEPTAL DEFECT 108 0.0129
201 DEHYDRATION 1717 0.0129
202 LOW BIRTH WEIGHT BABY 102 0.0128
203 MUSCLE TWITCHING 295 0.0128
204 ANURIA 110 0.0128
205 COLITIS 484 0.0128
206 TUMOUR LYSIS SYNDROME 112 0.0127
207 HYPERCALCAEMIA 157 0.0127
208 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 75 0.0126
209 RASH MACULO-PAPULAR 281 0.0126
210 HEPATIC CYTOLYSIS 161 0.0126
211 ASCITES 371 0.0126
212 PNEUMONITIS 343 0.0126
213 TACHYPNOEA 171 0.0126
214 UROSEPSIS 116 0.0126
215 ENCEPHALOPATHY 306 0.0124
216 LIVE BIRTH 104 0.0124
217 ENTEROCOCCAL INFECTION 60 0.0124
218 HAEMATEMESIS 314 0.0124
219 PROCTALGIA 79 0.0123
220 SPINAL COLUMN STENOSIS 58 0.0123
221 MACULAR DEGENERATION 146 0.0122
222 RHINITIS ALLERGIC 54 0.0121
223 BLOOD ALKALINE PHOSPHATASE INCREASED 301 0.0121
224 CHOLANGITIS 75 0.0121
225 MOUTH ULCERATION 254 0.0120
226 RESTLESSNESS 441 0.0120
227 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 61 0.0120
228 MUSCULOSKELETAL CHEST PAIN 186 0.0120
229 HAEMATOCRIT DECREASED 238 0.0120
230 FACIAL PAIN 106 0.0119
231 SEPTIC SHOCK 516 0.0118
232 HYPOCALCAEMIA 223 0.0118
233 ASPIRATION 129 0.0118
234 UPPER GASTROINTESTINAL HAEMORRHAGE 198 0.0118
235 VAGINAL DISCHARGE 119 0.0117
236 PREMATURE BABY 354 0.0117
237 PANCYTOPENIA 655 0.0117
238 LEUKOCYTOSIS 212 0.0117
239 ATAXIA 139 0.0117
240 HYPERTONIA 67 0.0117
241 VENTRICULAR SEPTAL DEFECT 67 0.0117
242 MULTI-ORGAN FAILURE 202 0.0117
243 PREMATURE DELIVERY 186 0.0117
244 CEREBRAL ISCHAEMIA 60 0.0116
245 PERIPHERAL VASCULAR DISORDER 60 0.0116
246 ACUTE RESPIRATORY FAILURE 223 0.0116
247 GASTRITIS EROSIVE 54 0.0116
248 EYE MOVEMENT DISORDER 79 0.0115
249 CHOLELITHIASIS 378 0.0115
250 ANOREXIA 148 0.0115
251 URINE OUTPUT DECREASED 100 0.0114
252 VENTRICULAR FIBRILLATION 127 0.0114
253 FLANK PAIN 107 0.0114
254 SUPRAVENTRICULAR TACHYCARDIA 109 0.0114
255 HYPOPHAGIA 291 0.0114
256 RENAL FAILURE 1508 0.0113
257 RENAL INJURY 336 0.0113
258 GENERALISED OEDEMA 140 0.0113
259 DIABETES MELLITUS INADEQUATE CONTROL 200 0.0113
260 MENTAL STATUS CHANGES 313 0.0113
261 DYSLIPIDAEMIA 57 0.0112
262 NEUTROPHIL COUNT DECREASED 455 0.0112
263 HYPERKALAEMIA 390 0.0111
264 PERIPHERAL SENSORY NEUROPATHY 65 0.0111
265 ISCHAEMIA 51 0.0111
266 ELECTROCARDIOGRAM ABNORMAL 87 0.0111
267 SEPSIS 1236 0.0111
268 SINUS BRADYCARDIA 107 0.0111
269 TOXIC ENCEPHALOPATHY 56 0.0110
270 ACUTE PULMONARY OEDEMA 62 0.0110
271 NORMAL NEWBORN 60 0.0110
272 BRAIN OEDEMA 139 0.0110
273 MYOCARDIAL ISCHAEMIA 125 0.0110
274 NEUTROPHIL COUNT INCREASED 112 0.0109
275 ORTHOSTATIC HYPOTENSION 189 0.0108
276 STEVENS-JOHNSON SYNDROME 240 0.0108
277 SPINAL COMPRESSION FRACTURE 89 0.0108
278 MULTIPLE MYELOMA 50 0.0107
279 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 110 0.0107
280 ADRENAL INSUFFICIENCY 130 0.0107
281 VOMITING 5024 0.0107
282 COVID-19 PNEUMONIA 126 0.0107
283 COMPRESSION FRACTURE 57 0.0106
284 HYPERBILIRUBINAEMIA 110 0.0106
285 FAECAL INCONTINENCE 51 0.0106
286 BLOOD SODIUM DECREASED 200 0.0106
287 FOETAL DEATH 55 0.0106
288 PANCREATITIS ACUTE 238 0.0106
289 OBESITY 168 0.0105
290 BLOOD BILIRUBIN INCREASED 282 0.0104
291 RENAL CELL CARCINOMA 51 0.0104
292 ANAEMIA 1983 0.0104
293 METASTASES TO LYMPH NODES 70 0.0104
294 HAEMORRHOIDS 202 0.0103
295 INTESTINAL PERFORATION 116 0.0103
296 ABDOMINAL PAIN 2380 0.0102
297 OSTEOPENIA 155 0.0102
298 STRESS CARDIOMYOPATHY 59 0.0101
299 DRUG INTERACTION 1609 0.0101
300 RESPIRATORY DEPRESSION 124 0.0101
301 REFUSAL OF TREATMENT BY PATIENT 66 0.0101
302 THROMBOCYTOPENIA 1130 0.0101
303 KLEBSIELLA INFECTION 51 0.0101
304 RESPIRATORY FAILURE 735 0.0101
305 HEPATIC FAILURE 302 0.0100
306 GAMMA-GLUTAMYLTRANSFERASE INCREASED 221 0.0100
307 PNEUMONIA ASPIRATION 247 0.0099
308 HYPERNATRAEMIA 49 0.0098
309 LYMPHOPENIA 139 0.0098
310 HYPERGLYCAEMIA 358 0.0098
311 GASTROOESOPHAGEAL REFLUX DISEASE 790 0.0098
312 SPUTUM DISCOLOURED 93 0.0098
313 GALLBLADDER DISORDER 175 0.0098
314 CONSTIPATION 2133 0.0098
315 PAIN 6005 0.0098
316 GRAND MAL CONVULSION 90 0.0097
317 NEPHROPATHY 91 0.0097
318 URINARY RETENTION 325 0.0097
319 METASTASES TO LIVER 171 0.0097
320 LUNG INFECTION 151 0.0097
321 FOETAL GROWTH RESTRICTION 59 0.0097
322 DRUG TOXICITY 132 0.0097
323 POLYNEUROPATHY 116 0.0097
324 LIPASE INCREASED 74 0.0096
325 FLUID OVERLOAD 140 0.0096
326 LYMPHOCYTE COUNT DECREASED 170 0.0096
327 PULMONARY HYPERTENSION 200 0.0096
328 LIVER FUNCTION TEST ABNORMAL 279 0.0096
329 SLEEP APNOEA SYNDROME 183 0.0096
330 METABOLIC ACIDOSIS 306 0.0096
331 TACHYCARDIA 846 0.0095
332 OLIGURIA 59 0.0095
333 APPETITE DISORDER 63 0.0095
334 ARTERIOSCLEROSIS 89 0.0094
335 DEVICE RELATED INFECTION 145 0.0094
336 RESPIRATORY SYNCYTIAL VIRUS INFECTION 82 0.0094
337 UNRESPONSIVE TO STIMULI 243 0.0094
338 HEPATIC STEATOSIS 174 0.0093
339 GASTROINTESTINAL MOTILITY DISORDER 50 0.0093
340 PULMONARY EMBOLISM 887 0.0093
341 GENERAL PHYSICAL HEALTH DETERIORATION 1079 0.0093
342 DYSPHAGIA 883 0.0093
343 EMBOLISM 77 0.0093
344 RESPIRATORY RATE INCREASED 82 0.0092
345 DELIRIUM 320 0.0092
346 HEPATIC ENCEPHALOPATHY 86 0.0092
347 MULTIPLE ORGAN DYSFUNCTION SYNDROME 261 0.0092
348 IRON DEFICIENCY ANAEMIA 85 0.0092
349 RECTAL HAEMORRHAGE 395 0.0092
350 CELLULITIS 461 0.0091
351 BACTERIAL INFECTION 170 0.0091
352 CHOLECYSTECTOMY 104 0.0091
353 DISABILITY 180 0.0091
354 NEUTROPENIA 1237 0.0091
355 BLOOD POTASSIUM DECREASED 273 0.0091
356 TROPONIN INCREASED 69 0.0091
357 ACUTE RESPIRATORY DISTRESS SYNDROME 160 0.0090
358 CARDIAC MURMUR 78 0.0090
359 HYPOGLYCAEMIA 436 0.0090
360 HEPATITIS CHOLESTATIC 54 0.0090
361 ENCEPHALITIS 62 0.0090
362 BLOOD CREATININE INCREASED 584 0.0089
363 SKIN INFECTION 100 0.0089
364 PERICARDIAL EFFUSION 206 0.0089
365 VENTRICULAR TACHYCARDIA 147 0.0089
366 CYANOSIS 140 0.0089
367 VENTRICULAR EXTRASYSTOLES 92 0.0089
368 HYPOTONIA 88 0.0088
369 JAUNDICE 237 0.0088
370 INCONTINENCE 93 0.0088
371 ANGIOEDEMA 389 0.0088
372 RALES 51 0.0088
373 METASTASES TO BONE 144 0.0088
374 HEPATITIS ACUTE 57 0.0088
375 ACIDOSIS 67 0.0088
376 ALANINE AMINOTRANSFERASE INCREASED 538 0.0088
377 CIRCULATORY COLLAPSE 149 0.0087
378 COLITIS ISCHAEMIC 59 0.0087
379 DEEP VEIN THROMBOSIS 568 0.0087
380 MATERNAL DRUGS AFFECTING FOETUS 67 0.0087
381 PYREXIA 3022 0.0087
382 ASPARTATE AMINOTRANSFERASE INCREASED 463 0.0087
383 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 65 0.0087
384 PYELONEPHRITIS 75 0.0086
385 CORONARY ARTERY DISEASE 262 0.0086
386 DUODENAL ULCER 61 0.0086
387 LARGE INTESTINE PERFORATION 60 0.0086
388 ORAL PAIN 193 0.0086
389 ORAL DISORDER 63 0.0086
390 RESPIRATORY DISTRESS 237 0.0086
391 CANDIDA INFECTION 145 0.0086
392 ACUTE CORONARY SYNDROME 71 0.0086
393 RIGHT VENTRICULAR FAILURE 60 0.0086
394 WALKING AID USER 56 0.0085
395 HYPERCHOLESTEROLAEMIA 82 0.0085
396 ANGINA UNSTABLE 55 0.0085
397 DECREASED APPETITE 1962 0.0084
398 BODY TEMPERATURE INCREASED 172 0.0084
399 BLEPHAROSPASM 53 0.0084
400 OSTEOPOROSIS 346 0.0084
401 SCOLIOSIS 52 0.0084
402 GASTRIC ULCER 159 0.0084
403 NAUSEA 6609 0.0083
404 DYSPEPSIA 821 0.0083
405 PETECHIAE 87 0.0083
406 BLOOD POTASSIUM INCREASED 134 0.0082
407 LEUKOPENIA 410 0.0082
408 DYSPHONIA 479 0.0082
409 HYPERPROLACTINAEMIA 53 0.0082
410 HYPOTENSION 1640 0.0082
411 PSEUDOMONAS INFECTION 70 0.0082
412 DYSARTHRIA 306 0.0081
413 CARDIAC ARREST 671 0.0081
414 WHITE BLOOD CELL COUNT INCREASED 311 0.0081
415 EATING DISORDER 172 0.0081
416 PNEUMOTHORAX 128 0.0081
417 SWELLING FACE 525 0.0081
418 PRESYNCOPE 196 0.0081
419 POST-TRAUMATIC STRESS DISORDER 54 0.0080
420 LOWER RESPIRATORY TRACT INFECTION 366 0.0080
421 PULMONARY OEDEMA 360 0.0080
422 FOETAL EXPOSURE DURING PREGNANCY 651 0.0080
423 HAEMOLYTIC ANAEMIA 71 0.0079
424 CARDIOMYOPATHY 117 0.0079
425 MYOSITIS 71 0.0079
426 HYPOTHYROIDISM 252 0.0079
427 BLOOD LACTATE DEHYDROGENASE INCREASED 125 0.0079
428 DISSEMINATED INTRAVASCULAR COAGULATION 111 0.0079
429 CARDIO-RESPIRATORY ARREST 329 0.0079
430 C-REACTIVE PROTEIN INCREASED 285 0.0078
431 MALIGNANT NEOPLASM PROGRESSION 802 0.0078
432 DROOLING 54 0.0078
433 CHOLESTASIS 150 0.0078
434 DEPRESSION 1775 0.0078
435 MAJOR DEPRESSION 57 0.0078
436 GINGIVAL PAIN 62 0.0078
437 MENINGITIS 52 0.0078
438 STOMATITIS 472 0.0078
439 INTESTINAL OBSTRUCTION 293 0.0078
440 ATRIAL FLUTTER 62 0.0078
441 DYSURIA 285 0.0077
442 HAEMODIALYSIS 65 0.0077
443 CONFUSIONAL STATE 1247 0.0077
444 DYSPNOEA EXERTIONAL 290 0.0077
445 ESCHERICHIA INFECTION 63 0.0077
446 CARDIAC FAILURE ACUTE 51 0.0076
447 SUDDEN DEATH 81 0.0076
448 MOTOR DYSFUNCTION 78 0.0076
449 INFUSION RELATED REACTION 507 0.0076
450 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 178 0.0076
451 HAEMOGLOBIN DECREASED 783 0.0076
452 RETCHING 162 0.0076
453 VITAMIN D DEFICIENCY 74 0.0076
454 OEDEMA PERIPHERAL 922 0.0076
455 HEPATOMEGALY 74 0.0075
456 ACUTE MYOCARDIAL INFARCTION 222 0.0075
457 PRODUCTIVE COUGH 359 0.0075
458 DEPRESSED LEVEL OF CONSCIOUSNESS 297 0.0075
459 INITIAL INSOMNIA 77 0.0075
460 LETHARGY 431 0.0075
461 VISUAL IMPAIRMENT 925 0.0075
462 ATRIAL FIBRILLATION 726 0.0074
463 PAIN IN JAW 211 0.0074
464 METASTASES TO CENTRAL NERVOUS SYSTEM 96 0.0074
465 HEPATITIS 189 0.0074
466 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 385 0.0074
467 DISORIENTATION 292 0.0074
468 FREQUENT BOWEL MOVEMENTS 199 0.0074
469 ABDOMINAL DISTENSION 768 0.0073
470 METASTASES TO LUNG 85 0.0073
471 BLADDER DISORDER 73 0.0073
472 MUSCLE ATROPHY 93 0.0073
473 AUTOIMMUNE HEPATITIS 51 0.0073
474 DECREASED ACTIVITY 79 0.0073
475 COAGULOPATHY 122 0.0073
476 BONE MARROW FAILURE 148 0.0073
477 PLATELET COUNT DECREASED 776 0.0073
478 INTERVERTEBRAL DISC PROTRUSION 159 0.0073
479 URINARY TRACT INFECTION 1240 0.0073
480 CONVULSION 415 0.0072
481 PROCEDURAL PAIN 201 0.0072
482 APHASIA 218 0.0072
483 APNOEA 56 0.0072
484 MYOPATHY 62 0.0072
485 STATUS EPILEPTICUS 81 0.0072
486 LOWER GASTROINTESTINAL HAEMORRHAGE 53 0.0072
487 ECCHYMOSIS 49 0.0071
488 PNEUMONIA 2304 0.0071
489 ASTHENIA 2674 0.0071
490 CONCUSSION 55 0.0071
491 STAPHYLOCOCCAL INFECTION 234 0.0071
492 HAEMODYNAMIC INSTABILITY 54 0.0071
493 HEMIPARESIS 120 0.0071
494 ERUCTATION 137 0.0071
495 NASAL DISCOMFORT 56 0.0071
496 ALTERED STATE OF CONSCIOUSNESS 153 0.0071
497 AGITATION 518 0.0070
498 BONE DISORDER 128 0.0070
499 TENDERNESS 73 0.0070
500 PERITONITIS 145 0.0070
501 PANCREATITIS 370 0.0070
502 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 383 0.0070
503 EOSINOPHILIA 122 0.0070
504 RIB FRACTURE 143 0.0069
505 SUICIDAL IDEATION 636 0.0069
506 HYPERTHERMIA 53 0.0069
507 SPEECH DISORDER 363 0.0069
508 DEMENTIA 193 0.0069
509 PULMONARY CONGESTION 91 0.0069
510 ANAPHYLACTIC REACTION 380 0.0069
511 DENTAL CARIES 76 0.0069
512 OSTEOARTHRITIS 291 0.0069
513 HAEMATURIA 235 0.0069
514 GROIN PAIN 60 0.0068
515 PLATELET COUNT INCREASED 89 0.0068
516 DISEASE PROGRESSION 806 0.0068
517 UPPER-AIRWAY COUGH SYNDROME 56 0.0068
518 SYNCOPE 679 0.0068
519 MELAENA 149 0.0068
520 ABSCESS 108 0.0068
521 NEUROTOXICITY 118 0.0067
522 SECOND PRIMARY MALIGNANCY 56 0.0067
523 AGRANULOCYTOSIS 125 0.0067
524 BLOOD PRESSURE SYSTOLIC INCREASED 131 0.0067
525 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 64 0.0067
526 PURPURA 59 0.0067
527 ACUTE HEPATIC FAILURE 91 0.0067
528 SPLENOMEGALY 78 0.0067
529 BRONCHOSPASM 95 0.0067
530 TRANSAMINASES INCREASED 148 0.0066
531 PNEUMONIA BACTERIAL 61 0.0066
532 EMPHYSEMA 67 0.0066
533 DIARRHOEA HAEMORRHAGIC 62 0.0066
534 OSTEOMYELITIS 120 0.0066
535 MATERNAL EXPOSURE DURING PREGNANCY 590 0.0066
536 POST PROCEDURAL COMPLICATION 127 0.0066
537 PARANOIA 114 0.0066
538 PHARYNGITIS 82 0.0066
539 POISONING 83 0.0066
540 RESPIRATORY TRACT INFECTION 172 0.0066
541 HEPATOTOXICITY 147 0.0066
542 NEPHROPATHY TOXIC 74 0.0066
543 URINARY INCONTINENCE 195 0.0066
544 WEIGHT DECREASED 1835 0.0066
545 HAEMOPTYSIS 183 0.0066
546 ANAL INCONTINENCE 59 0.0066
547 FEEDING DISORDER 133 0.0066
548 CHEST PAIN 1212 0.0065
549 UPPER RESPIRATORY TRACT INFECTION 302 0.0065
550 EAR PAIN 127 0.0065
551 GENERALISED TONIC-CLONIC SEIZURE 108 0.0065
552 GLOMERULAR FILTRATION RATE DECREASED 80 0.0065
553 SALIVARY HYPERSECRETION 65 0.0065
554 SEDATION 170 0.0065
555 DIARRHOEA 4185 0.0065
556 PNEUMOCYSTIS JIROVECII PNEUMONIA 65 0.0065
557 RED BLOOD CELL COUNT DECREASED 185 0.0065
558 BRADYCARDIA 343 0.0065
559 CAESAREAN SECTION 75 0.0064
560 NEOPLASM PROGRESSION 224 0.0064
561 EXPOSURE DURING PREGNANCY 400 0.0064
562 OXYGEN SATURATION DECREASED 361 0.0064
563 TOOTH ABSCESS 65 0.0064
564 PULMONARY MASS 95 0.0064
565 BLOOD DISORDER 51 0.0064
566 SENSORY LOSS 51 0.0063
567 FIBROMYALGIA 154 0.0063
568 RENAL IMPAIRMENT 530 0.0063
569 SUBARACHNOID HAEMORRHAGE 64 0.0063
570 CARDIOGENIC SHOCK 90 0.0063
571 GASTROINTESTINAL PAIN 69 0.0063
572 DIABETIC KETOACIDOSIS 150 0.0062
573 SKIN ULCER 161 0.0062
574 ABNORMAL FAECES 51 0.0062
575 BODY TEMPERATURE DECREASED 61 0.0062
576 MUSCLE DISORDER 50 0.0062
577 INTERNATIONAL NORMALISED RATIO INCREASED 176 0.0062
578 NERVE INJURY 68 0.0061
579 OEDEMA 331 0.0061
580 FACIAL PARALYSIS 52 0.0061
581 TYPE 2 DIABETES MELLITUS 205 0.0061
582 SHOCK 140 0.0061
583 HYPERTHYROIDISM 88 0.0061
584 HYPERTENSION 1286 0.0061
585 FUNGAL INFECTION 202 0.0061
586 MYELODYSPLASTIC SYNDROME 86 0.0059
587 MIGRAINE 566 0.0059
588 IRRITABLE BOWEL SYNDROME 127 0.0059
589 RHABDOMYOLYSIS 247 0.0059
590 EXOSTOSIS 54 0.0059
591 HYPERHIDROSIS 761 0.0059
592 FEELING COLD 164 0.0059
593 SPINAL FRACTURE 118 0.0059
594 ABDOMINAL PAIN UPPER 1210 0.0059
595 HAEMATOCHEZIA 324 0.0059
596 TRANSIENT ISCHAEMIC ATTACK 198 0.0059
597 DYSPNOEA 3321 0.0059
598 BACK PAIN 1362 0.0059
599 VASCULITIS 68 0.0058
600 GASTROENTERITIS VIRAL 105 0.0058
601 NEURALGIA 141 0.0058
602 ARRHYTHMIA 274 0.0058
603 NOCTURIA 70 0.0058
604 FAECES DISCOLOURED 124 0.0057
605 NAIL DISORDER 50 0.0057
606 BLOOD PRESSURE DECREASED 379 0.0057
607 CARDIAC FAILURE CONGESTIVE 458 0.0057
608 FACE OEDEMA 96 0.0057
609 WOUND INFECTION 62 0.0057
610 PALLOR 154 0.0057
611 PARALYSIS 81 0.0057
612 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 50 0.0056
613 ULCER 89 0.0056
614 LACTIC ACIDOSIS 181 0.0056
615 PANIC ATTACK 203 0.0056
616 CARPAL TUNNEL SYNDROME 78 0.0056
617 DIZZINESS POSTURAL 54 0.0056
618 EPISTAXIS 415 0.0055
619 MUSCULAR WEAKNESS 628 0.0055
620 CLOSTRIDIUM DIFFICILE INFECTION 120 0.0055
621 LACRIMATION INCREASED 166 0.0055
622 COGNITIVE DISORDER 256 0.0055
623 CHROMATURIA 123 0.0054
624 HEPATOCELLULAR INJURY 77 0.0054
625 DIALYSIS 77 0.0054
626 OSTEONECROSIS OF JAW 134 0.0054
627 GASTROINTESTINAL HAEMORRHAGE 451 0.0054
628 GASTROINTESTINAL DISORDER 482 0.0054
629 SUBDURAL HAEMATOMA 77 0.0054
630 ABDOMINAL PAIN LOWER 136 0.0054
631 BLOOD TRIGLYCERIDES INCREASED 95 0.0054
632 DRY MOUTH 435 0.0054
633 HALLUCINATION 404 0.0054
634 LYMPHADENOPATHY 189 0.0053
635 DIABETES MELLITUS 407 0.0053
636 COLD SWEAT 94 0.0053
637 TOXICITY TO VARIOUS AGENTS 899 0.0053
638 NO THERAPEUTIC RESPONSE 65 0.0053
639 PHOTOPHOBIA 100 0.0053
640 OBSTRUCTIVE AIRWAYS DISORDER 59 0.0053
641 HYPERTENSIVE CRISIS 59 0.0053
642 CHILLS 619 0.0053
643 MEDICATION ERROR 293 0.0053
644 DRUG EXPOSURE DURING PREGNANCY 179 0.0053
645 EAR DISCOMFORT 54 0.0053
646 ERYTHEMA MULTIFORME 49 0.0052
647 MUSCULOSKELETAL PAIN 275 0.0052
648 CARDIAC FAILURE 421 0.0052
649 HYPERSENSITIVITY 970 0.0052
650 MYDRIASIS 67 0.0052
651 WHITE BLOOD CELL COUNT DECREASED 566 0.0052
652 RESPIRATORY DISORDER 156 0.0052
653 BREAST CANCER METASTATIC 56 0.0052
654 NODULE 68 0.0052
655 LACERATION 49 0.0052
656 BRONCHITIS 385 0.0052
657 LOSS OF CONSCIOUSNESS 663 0.0052
658 CYTOMEGALOVIRUS INFECTION 86 0.0052
659 BACK INJURY 56 0.0051
660 FEELING JITTERY 98 0.0051
661 NECK PAIN 287 0.0051
662 CYSTITIS 163 0.0051
663 SKIN LESION 140 0.0051
664 DRUG-INDUCED LIVER INJURY 160 0.0051
665 THIRST 91 0.0051
666 HEAD INJURY 161 0.0051
667 BRAIN INJURY 51 0.0051
668 INTERSTITIAL LUNG DISEASE 246 0.0051
669 HAEMATOMA 131 0.0051
670 LIMB DISCOMFORT 156 0.0050
671 HYPOTHERMIA 51 0.0050
672 VERTIGO 307 0.0050
673 TOOTHACHE 91 0.0050
674 DRUG ERUPTION 89 0.0050
675 BALANCE DISORDER 434 0.0050
676 ROTATOR CUFF SYNDROME 64 0.0050
677 SCAR 85 0.0050
678 PROTEINURIA 94 0.0049
679 TOOTH INFECTION 65 0.0049
680 TASTE DISORDER 100 0.0049
681 CYTOPENIA 60 0.0049
682 CORONARY ARTERY OCCLUSION 67 0.0049
683 PERIPHERAL COLDNESS 67 0.0049
684 SPINAL PAIN 57 0.0049
685 PULMONARY FIBROSIS 93 0.0048
686 PELVIC PAIN 88 0.0048
687 HEPATIC FUNCTION ABNORMAL 180 0.0048
688 DIPLOPIA 125 0.0048
689 SOMNOLENCE 968 0.0048
690 CONDITION AGGRAVATED 1458 0.0048
691 ABASIA 118 0.0048
692 CHEST DISCOMFORT 489 0.0048
693 COUGH 1334 0.0048
694 MUSCLE TIGHTNESS 77 0.0047
695 ACUTE MYELOID LEUKAEMIA 74 0.0047
696 FALL 1580 0.0047
697 HEART RATE INCREASED 470 0.0047
698 HEPATIC CIRRHOSIS 89 0.0047
699 COORDINATION ABNORMAL 66 0.0047
700 JOINT DISLOCATION 50 0.0047
701 MICTURITION URGENCY 54 0.0047
702 RESPIRATORY ARREST 130 0.0047
703 FLATULENCE 267 0.0047
704 GOUT 84 0.0047
705 FATIGUE 3645 0.0047
706 OROPHARYNGEAL PAIN 433 0.0047
707 CHOKING 91 0.0047
708 DIVERTICULITIS 129 0.0047
709 PULMONARY ARTERIAL HYPERTENSION 67 0.0046
710 BONE PAIN 270 0.0046
711 ACCIDENT 55 0.0046
712 NEPHROLITHIASIS 211 0.0046
713 INFECTION 665 0.0046
714 SEASONAL ALLERGY 65 0.0046
715 INFUSION SITE PAIN 59 0.0046
716 LIVER FUNCTION TEST INCREASED 98 0.0046
717 SENSORY DISTURBANCE 73 0.0045
718 BURSITIS 55 0.0045
719 CONJUNCTIVITIS 84 0.0045
720 ANKLE FRACTURE 70 0.0045
721 ANGINA PECTORIS 129 0.0045
722 HAEMORRHAGE INTRACRANIAL 67 0.0045
723 DRUG LEVEL INCREASED 74 0.0045
724 ABNORMAL BEHAVIOUR 177 0.0045
725 POST PROCEDURAL HAEMORRHAGE 52 0.0045
726 SEIZURE 512 0.0044
727 FOOT FRACTURE 84 0.0044
728 CEREBRAL INFARCTION 108 0.0044
729 WHEEZING 262 0.0044
730 LIP SWELLING 147 0.0044
731 HALLUCINATION, VISUAL 93 0.0044
732 PSYCHOMOTOR HYPERACTIVITY 73 0.0044
733 HYPOAESTHESIA 658 0.0044
734 SECRETION DISCHARGE 55 0.0044
735 ORAL DISCOMFORT 61 0.0044
736 VIRAL INFECTION 146 0.0044
737 MUSCLE SPASMS 804 0.0044
738 BLISTER 246 0.0044
739 BLOOD URINE PRESENT 83 0.0044
740 MASS 61 0.0044
741 DEPRESSED MOOD 230 0.0043
742 NEOPLASM 50 0.0043
743 MOBILITY DECREASED 309 0.0043
744 DRUG INTOLERANCE 414 0.0043
745 COMA 204 0.0043
746 MYOCARDITIS 49 0.0043
747 PALPITATIONS 498 0.0042
748 AMNESIA 276 0.0042
749 DIZZINESS 2115 0.0042
750 TREATMENT NONCOMPLIANCE 232 0.0042
751 MALAISE 1859 0.0042
752 POOR QUALITY SLEEP 91 0.0042
753 DYSGEUSIA 311 0.0042
754 GINGIVAL BLEEDING 57 0.0042
755 BLOOD PRESSURE FLUCTUATION 100 0.0042
756 SCIATICA 66 0.0041
757 HEADACHE 2592 0.0041
758 TENDONITIS 64 0.0041
759 KIDNEY INFECTION 81 0.0041
760 JOINT RANGE OF MOTION DECREASED 55 0.0041
761 INSOMNIA 1091 0.0041
762 ISCHAEMIC STROKE 73 0.0041
763 TINNITUS 187 0.0041
764 HYPOAESTHESIA ORAL 61 0.0040
765 FEMUR FRACTURE 125 0.0040
766 GAIT DISTURBANCE 771 0.0040
767 BLOOD PRESSURE ABNORMAL 80 0.0040
768 BRAIN FOG 63 0.0040
769 LOCALISED INFECTION 97 0.0040
770 CONTUSION 386 0.0040
771 POLLAKIURIA 166 0.0040
772 DERMATITIS 83 0.0040
773 HEART RATE IRREGULAR 89 0.0039
774 HERNIA 76 0.0039
775 PARAESTHESIA 617 0.0039
776 BLOOD TEST ABNORMAL 55 0.0039
777 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 188 0.0039
778 NIGHT SWEATS 126 0.0039
779 MULTIPLE FRACTURES 64 0.0039
780 GLOSSODYNIA 87 0.0039
781 MALIGNANT MELANOMA 52 0.0039
782 FULL BLOOD COUNT DECREASED 78 0.0039
783 PERICARDITIS 65 0.0039
784 COLITIS ULCERATIVE 172 0.0038
785 NERVOUSNESS 201 0.0038
786 GASTRIC DISORDER 132 0.0038
787 SKIN FISSURES 75 0.0038
788 BLOOD PRESSURE INCREASED 585 0.0038
789 BEDRIDDEN 50 0.0038
790 FLUSHING 386 0.0038
791 CENTRAL NERVOUS SYSTEM LESION 52 0.0038
792 MUSCULOSKELETAL DISCOMFORT 65 0.0038
793 EPILEPSY 115 0.0038
794 CEREBRAL HAEMORRHAGE 134 0.0037
795 SINUSITIS 382 0.0037
796 WOUND 104 0.0037
797 HYPOKINESIA 54 0.0037
798 COLON CANCER 55 0.0037
799 GAIT INABILITY 123 0.0037
800 CEREBROVASCULAR ACCIDENT 622 0.0037
801 THERAPY NON-RESPONDER 165 0.0037
802 PAIN IN EXTREMITY 1077 0.0037
803 FEELING HOT 224 0.0037
804 PRURITUS GENERALISED 79 0.0036
805 OFF LABEL USE 3183 0.0036
806 DISTURBANCE IN ATTENTION 196 0.0036
807 HYPERSOMNIA 104 0.0036
808 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 62 0.0036
809 SLEEP DISORDER 255 0.0036
810 ERYTHEMA 735 0.0036
811 PHARYNGEAL OEDEMA 55 0.0036
812 BLOOD GLUCOSE ABNORMAL 66 0.0036
813 LIVER DISORDER 158 0.0036
814 TOOTH LOSS 73 0.0035
815 DRUG PRESCRIBING ERROR 67 0.0035
816 PRODUCT USE IN UNAPPROVED INDICATION 861 0.0035
817 INTENTIONAL PRODUCT USE ISSUE 303 0.0035
818 ARTHRITIS 272 0.0035
819 BLOOD GLUCOSE DECREASED 166 0.0035
820 HIP FRACTURE 111 0.0034
821 LUNG DISORDER 169 0.0034
822 SWELLING 322 0.0034
823 LOCAL SWELLING 60 0.0034
824 RENAL DISORDER 160 0.0034
825 APATHY 50 0.0034
826 MUSCULOSKELETAL STIFFNESS 299 0.0034
827 ABDOMINAL DISCOMFORT 572 0.0034
828 PLASMA CELL MYELOMA 133 0.0034
829 HEPATIC ENZYME INCREASED 231 0.0034
830 LOWER LIMB FRACTURE 65 0.0034
831 BLOOD CREATINE PHOSPHOKINASE INCREASED 97 0.0034
832 PRODUCT PRESCRIBING ERROR 80 0.0034
833 JOINT STIFFNESS 88 0.0034
834 SKIN DISCOLOURATION 154 0.0033
835 DISCOMFORT 204 0.0033
836 FLUID RETENTION 169 0.0033
837 IMPAIRED HEALING 109 0.0033
838 ILL-DEFINED DISORDER 200 0.0033
839 THROAT TIGHTNESS 89 0.0033
840 VISION BLURRED 451 0.0033
841 SINUS DISORDER 65 0.0033
842 ALOPECIA 644 0.0033
843 EAR INFECTION 87 0.0033
844 BASAL CELL CARCINOMA 51 0.0033
845 MYALGIA 555 0.0033
846 LIVER INJURY 79 0.0032
847 RHINORRHOEA 208 0.0032
848 RASH 1402 0.0032
849 MIDDLE INSOMNIA 60 0.0032
850 UPPER LIMB FRACTURE 64 0.0032
851 OVERDOSE 692 0.0032
852 THROMBOSIS 258 0.0032
853 RASH MACULAR 112 0.0032
854 LIMB INJURY 87 0.0032
855 ASTHMA 360 0.0032
856 PSYCHOTIC DISORDER 94 0.0032
857 MYOCARDIAL INFARCTION 552 0.0032
858 BLOOD CHOLESTEROL INCREASED 147 0.0032
859 ARTHRALGIA 1311 0.0031
860 ANAPHYLACTIC SHOCK 81 0.0031
861 BLINDNESS 128 0.0031
862 CONTRAINDICATED PRODUCT ADMINISTERED 95 0.0031
863 MENTAL IMPAIRMENT 76 0.0031
864 RASH GENERALISED 81 0.0031
865 ORAL HERPES 61 0.0031
866 HEART RATE DECREASED 109 0.0031
867 SKIN DISORDER 103 0.0031
868 DYSSTASIA 89 0.0030
869 INCREASED APPETITE 58 0.0030
870 BURNING SENSATION 211 0.0030
871 EYE PRURITUS 101 0.0030
872 RASH ERYTHEMATOUS 143 0.0030
873 RASH PRURITIC 162 0.0030
874 DEAFNESS 78 0.0030
875 ACCIDENTAL OVERDOSE 109 0.0030
876 DRUG ABUSE 248 0.0030
877 CRYING 108 0.0030
878 INFLUENZA 330 0.0030
879 CARDIOVASCULAR DISORDER 75 0.0030
880 PERIPHERAL SWELLING 452 0.0029
881 CATARACT 174 0.0029
882 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 75 0.0029
883 HERPES ZOSTER 167 0.0029
884 MEMORY IMPAIRMENT 397 0.0029
885 INCORRECT PRODUCT ADMINISTRATION DURATION 62 0.0029
886 CARDIAC DISORDER 266 0.0028
887 PRESCRIBED OVERDOSE 55 0.0028
888 MYELOSUPPRESSION 102 0.0028
889 JOINT INJURY 60 0.0028
890 INFLAMMATION 144 0.0028
891 BLOOD GLUCOSE INCREASED 524 0.0028
892 LABORATORY TEST ABNORMAL 82 0.0028
893 NASAL CONGESTION 162 0.0028
894 FEELING ABNORMAL 657 0.0027
895 PRURITUS 1041 0.0027
896 WEIGHT INCREASED 605 0.0027
897 GLAUCOMA 52 0.0027
898 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 192 0.0027
899 TOOTH DISORDER 60 0.0027
900 COMPLETED SUICIDE 224 0.0027
901 PAIN OF SKIN 72 0.0027
902 NEOPLASM MALIGNANT 178 0.0027
903 ROAD TRAFFIC ACCIDENT 110 0.0026
904 HOT FLUSH 198 0.0026
905 ARTHROPATHY 146 0.0026
906 SUICIDE ATTEMPT 159 0.0026
907 INTENTIONAL OVERDOSE 168 0.0026
908 ERECTILE DYSFUNCTION 67 0.0026
909 RASH PAPULAR 58 0.0026
910 PRODUCT ADMINISTRATION ERROR 52 0.0026
911 HAEMORRHAGE 267 0.0026
912 INTENTIONAL DRUG MISUSE 53 0.0025
913 PANCREATIC CARCINOMA 71 0.0025
914 ILLNESS 252 0.0024
915 DEVICE DISLOCATION 105 0.0024
916 IRRITABILITY 145 0.0024
917 ECZEMA 126 0.0024
918 AGEUSIA 60 0.0024
919 DEATH 2055 0.0024
920 OSTEONECROSIS 77 0.0023
921 NIGHTMARE 81 0.0023
922 ABNORMAL DREAMS 64 0.0023
923 SKIN EXFOLIATION 195 0.0023
924 BONE DENSITY DECREASED 72 0.0023
925 GASTRIC CANCER 58 0.0023
926 INFLUENZA LIKE ILLNESS 188 0.0023
927 EYE DISORDER 75 0.0023
928 JOINT SWELLING 275 0.0023
929 MOOD ALTERED 62 0.0023
930 EYE PAIN 126 0.0022
931 COVID-19 391 0.0022
932 VISUAL ACUITY REDUCED 74 0.0022
933 DRY SKIN 295 0.0022
934 NASOPHARYNGITIS 405 0.0022
935 AGGRESSION 109 0.0022
936 SURGERY 127 0.0022
937 DRY EYE 108 0.0022
938 ADVERSE EVENT 199 0.0022
939 PHARMACEUTICAL PRODUCT COMPLAINT 56 0.0022
940 WITHDRAWAL SYNDROME 88 0.0021
941 THERAPEUTIC RESPONSE UNEXPECTED 94 0.0021
942 THROAT IRRITATION 94 0.0021
943 GLYCOSYLATED HAEMOGLOBIN INCREASED 52 0.0021
944 MOOD SWINGS 65 0.0020
945 URTICARIA 340 0.0020
946 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 364 0.0020
947 PRODUCT USE ISSUE 370 0.0020
948 VAGINAL HAEMORRHAGE 85 0.0020
949 DRUG ADMINISTRATION ERROR 60 0.0020
950 LUNG NEOPLASM MALIGNANT 80 0.0019
951 TREATMENT FAILURE 160 0.0019
952 ANGER 65 0.0019
953 WRONG TECHNIQUE IN DRUG USAGE PROCESS 69 0.0019
954 HOSPITALISATION 291 0.0019
955 INTENTIONAL PRODUCT MISUSE 160 0.0018
956 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 129 0.0018
957 DRUG INEFFECTIVE 2319 0.0018
958 SYSTEMIC LUPUS ERYTHEMATOSUS 62 0.0017
959 ADVERSE DRUG REACTION 154 0.0017
960 DRUG WITHDRAWAL SYNDROME 147 0.0017
961 EYE SWELLING 62 0.0017
962 ABORTION SPONTANEOUS 66 0.0016
963 THERAPEUTIC RESPONSE DECREASED 97 0.0016
964 DEVICE MALFUNCTION 112 0.0016
965 OCULAR HYPERAEMIA 74 0.0016
966 MULTIPLE SCLEROSIS 74 0.0015
967 DRUG DEPENDENCE 239 0.0015
968 UNDERDOSE 108 0.0015
969 DISEASE RECURRENCE 69 0.0014
970 DRUG EFFECT DECREASED 78 0.0014
971 INJECTION SITE MASS 52 0.0014
972 BREAST CANCER 131 0.0014
973 RHEUMATOID ARTHRITIS 157 0.0014
974 MULTIPLE SCLEROSIS RELAPSE 91 0.0013
975 PRODUCT DOSE OMISSION ISSUE 383 0.0013
976 DRUG DOSE OMISSION 214 0.0013
977 PRODUCT QUALITY ISSUE 169 0.0012
978 HYPOACUSIS 52 0.0012
979 INCORRECT DOSE ADMINISTERED 266 0.0012
980 EYE IRRITATION 67 0.0012
981 THERAPY INTERRUPTED 82 0.0011
982 PRODUCT SUBSTITUTION ISSUE 60 0.0010
983 INJECTION SITE REACTION 68 0.0010
984 INJECTION SITE ERYTHEMA 119 0.0010
985 INJECTION SITE PAIN 268 0.0009
986 INJECTION SITE HAEMORRHAGE 68 0.0009
987 INJECTION SITE BRUISING 67 0.0008
988 INJECTION SITE SWELLING 64 0.0008
989 PRODUCT DOSE OMISSION 53 0.0008
990 PSORIASIS 104 0.0008
991 INJECTION SITE PRURITUS 53 0.0008
992 DEVICE ISSUE 66 0.0007
993 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 135 0.0007
994 ACNE 50 0.0007
995 NO ADVERSE EVENT 73 0.0004